ALKAMI TECHNOLOGY, INC.·4

Nov 22, 6:03 PM ET

Linebarger Douglas A. 4

4 · ALKAMI TECHNOLOGY, INC. · Filed Nov 22, 2024

Insider Transaction Report

Form 4
Period: 2024-11-20
Linebarger Douglas A.
Chief Legal Officer
Transactions
  • Sale

    Common Stock

    2024-11-21$38.28/sh29,612$1,133,450262,309 total
  • Exercise/Conversion

    Common Stock

    2024-11-21$15.46/sh+43,336$669,975291,921 total
  • Exercise/Conversion

    Common Stock

    2024-11-20$15.46/sh+12,079$186,741260,664 total
  • Sale

    Common Stock

    2024-11-21$38.99/sh13,724$535,118248,585 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-11-2012,07947,561 total
    Exercise: $15.46Exp: 2031-02-05Common Stock (12,079 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-11-2143,3364,225 total
    Exercise: $15.46Exp: 2031-02-05Common Stock (43,336 underlying)
  • Sale

    Common Stock

    2024-11-20$38.08/sh12,079$459,971248,585 total
Footnotes (4)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transaction of prices ranging from $38.00 to $38.225. The Reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transaction of prices ranging from $37.80 to $38.79. The Reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transaction of prices ranging from $38.825 to $39.10. The Reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]The options are fully vested and exercisable.

Documents

1 file
  • 4
    wk-form4_1732316607.xmlPrimary

    FORM 4